U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C6H6
Molecular Weight 78.1118
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of Benzene

SMILES

C1=CC=CC=C1

InChI

InChIKey=UHOVQNZJYSORNB-UHFFFAOYSA-N
InChI=1S/C6H6/c1-2-4-6-5-3-1/h1-6H

HIDE SMILES / InChI

Molecular Formula C6H6
Molecular Weight 78.1118
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Phenyl sodium is organometallic compound. It is used to carry exchange reactions to produce phenylmalonic acid.

Originator

Curator's Comment: Am. Chem. Journal, 29, 589 (1903).

Approval Year

Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
PubMed

PubMed

TitleDatePubMed
Formation and inhibition of chloroaromatic micropollutants formed in incineration processes.
2001-04
Air pollution from traffic at the residence of children with cancer.
2001-03-01
Oxidation of polychlorinated benzenes by genetically engineered CYP101 (cytochrome P450(cam)).
2001-03
Induction and time-dependent accumulation of micronuclei in peripheral blood of transgenic p53+/- mice, Tg.AC (v-Ha-ras) and parental wild-type (C57BL/6 and FVB/N) mice exposed to benzene by inhalation.
2001-03
Investigation of the in vitro metabolism profile of a phosphodiesterase-IV inhibitor, CDP-840: leading to structural optimization.
2001-03
In vitro inhibition of cytochrome P450 enzymes in human liver microsomes by a potent CYP2A6 inhibitor, trans-2-phenylcyclopropylamine (tranylcypromine), and its nonamine analog, cyclopropylbenzene.
2001-03
Interactions of tryptamine derivatives with serotonin transporter species variants implicate transmembrane domain I in substrate recognition.
2001-03
Amino acid residues critical for differential inhibition of CYP2B4, CYP2B5, and CYP2B1 by phenylimidazoles.
2001-03
Characterization of emissions during the heating of tyre contaminated scrap.
2001-02-24
An experimental and numerical study of the thermal oxidation of chlorobenzene.
2001-02-24
Thermal destruction of benzene.
2001-02-24
Hazardous air pollutants formation from reactions of raw meal organics in cement kilns.
2001-02-24
Benzene-induced myelodysplastic syndrome.
2001-02-24
DFT/ECP study of C-H activation by (PCP)Ir and (PCP)Ir(H)2(PCP=eta3-1,3-C6H3(CH2PR2)2). Enthalpies and free energies of associative and dissociative pathways.
2001-02-24
Photorearrangement of vinylidenecyclopropanes to 1,2,3-butatriene derivatives.
2001-02-22
Multicomponent polyanions. 57. Large-angle X-ray scattering study of aqueous molybdophenylphosphonate solutions.
2001-02-12
Miniaturized solid-phase extraction with resin disks.
2001-02-09
Preparation and applications of polypyrrole films in solid-phase microextraction.
2001-02-09
Combining membrane extraction with mobile gas chromatography for the field analysis of volatile organic compounds in contaminated waters.
2001-02-09
Application of on-site solid-phase microextraction in aquatic dissipation studies of profoxydim in rice.
2001-02-09
Adsorbate-substrate vibrational modes of benzene on Ag(110) resolved with scanning tunneling spectroscopy.
2001-02-05
Protective effects of SM-20302, an orally active GPIIb/IIIa antagonist, in an ADP/epinephrine-induced guinea pig model of transient cerebral ischemia.
2001-02-01
Photocleavage of DNA by 4'-bromoacetophenone analogs.
2001-02
Caffeic acid phenethyl ester (CAPE): synthesis and X-ray crystallographic analysis.
2001-02
Phosphodiesterase 4 isoenzyme inhibitory activity of 3-phenylxanthines and 4-pheny.
2001-02
Absorption spectroscopic study of EDA complexes of.
2001-02
Sensitive and rapid method for the simultaneous quantification of the HIV-protease inhibitors indinavir, nelfinavir, ritonavir, and saquinavir in human plasma by reversed-phase liquid chromatography.
2001-02
Urinary benzene as a biomarker of exposure among occupationally exposed and unexposed subjects.
2001-02
Antagonists of the human CCR5 receptor as anti-HIV-1 agents. Part 2: structure-activity relationships for substituted 2-Aryl-1-[N-(methyl)-N-(phenylsulfonyl)amino]-4-(piperidin-1-yl)butanes.
2001-01-22
Design and synthesis of sialyl Lewis x mimics as E-selectin inhibitors.
2001-01-22
Characterization of the polarity of reversed-phase liquid chromatographic stationary phases in the presence of 1-propanol using solvatochromism and multivariate curve resolution.
2001-01-15
Towards a correlation of absolute configuration and chiroptical properties of alkyl aryl sulfoxides: a coupled-oscillator foundation of the empirical Mislow rule?
2001-01-05
Self-assembly and selective guest binding of three-dimensional open-framework solids from a macrocyclic complex as a trifunctional metal building block.
2001-01-05
Quantification of derivatives of bisphenol A diglycidyl ether (BADGE) and novolac glycidyl ether (NOGE) migrated from can coatings into tuna by HPLC/fluorescence and MS detection.
2001-01-02
Copper(II) complexes with phenoxyalkanoic acids and nitrogen donor heterocyclic ligands: structure and bioactivity.
2001-01-01
BTEX catabolism interactions in a toluene-acclimatized biofilter.
2001-01
The disposition and metabolism of durene (1,2,4,5-tetramethylbenzene) in rats.
2001-01
[Physical chemical, pharmacological and toxicologic properties of fomocaine metabolites] .
2001-01
Desulfosporosinus meridiei sp. nov., a spore-forming sulfate-reducing bacterium isolated from gasolene-contaminated groundwater.
2001-01
Interfacial study of benzenesulfinate chemisorbed on silver.
2001-01
Determination of low concentrations of benzene in urine using multi-dimensional gas chromatography.
2001-01
Electric field-induced mobilisation of multiphase solution systems based on the nitration of benzene in a micro reactor.
2001-01
Solute-stationary phase interaction in gas liquid chromatography. Thermodynamic parameters for substituted halogenobenzene derivatives.
2001-01
N-nitrosoanilines: a new class of caspase-3 inhibitors.
2001-01
Triarylpyrazoles with basic side chains: development of pyrazole-based estrogen receptor antagonists.
2001-01
Comparison of binding of tetraphenylborate and tetraphenylphosphonium ions to cyclodextrins studied by capillary electrophoresis.
2001-01
Biological monitoring of workers exposed to ethylbenzene and co-exposed to xylene.
2001-01
Bioconversion of vitamin E acetate in human skin.
2001
Chemoprevention of benzene-induced bone marrow and pulmonary genotoxicity.
2001
Analysis of DNA damage using capillary zone electrophoresis and electrospray mass spectrometry.
2001
Patents

Sample Use Guides

In Vivo Use Guide
Unknown
Route of Administration: Unknown
In Vitro Use Guide
Unknown
Substance Class Chemical
Created
by admin
on Mon Mar 31 17:35:15 GMT 2025
Edited
by admin
on Mon Mar 31 17:35:15 GMT 2025
Record UNII
J64922108F
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
Benzene
HSDB   MART.   MI   VANDF   WHO-DD  
Systematic Name English
BENZINUM
HPUS  
Preferred Name English
BENZENE [IARC]
Common Name English
COAL NAPHTHA
Common Name English
BENZENE [USP-RS]
Common Name English
BIPERIDEN HYDROCHLORIDE IMPURITY F [EP IMPURITY]
Common Name English
1,3,5-CYCLOHEXATRIENE
Systematic Name English
BENZENE (BENZOL)
Systematic Name English
BENZENE [MART.]
Common Name English
BENZENE [HSDB]
Common Name English
NCI-C55276
Common Name English
ACETONE IMPURITY C [EP IMPURITY]
Common Name English
NSC-67315
Code English
CYCLOHEXATRIENE
Systematic Name English
Benzene [WHO-DD]
Common Name English
BENZINUM [HPUS]
Common Name English
BENZENE [VANDF]
Common Name English
BENZENE [MI]
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C44351
Created by admin on Mon Mar 31 17:35:15 GMT 2025 , Edited by admin on Mon Mar 31 17:35:15 GMT 2025
IARC Benzene
NCI_THESAURUS C1915
Created by admin on Mon Mar 31 17:35:15 GMT 2025 , Edited by admin on Mon Mar 31 17:35:15 GMT 2025
Code System Code Type Description
ECHA (EC/EINECS)
200-753-7
Created by admin on Mon Mar 31 17:35:15 GMT 2025 , Edited by admin on Mon Mar 31 17:35:15 GMT 2025
PRIMARY
HSDB
34
Created by admin on Mon Mar 31 17:35:15 GMT 2025 , Edited by admin on Mon Mar 31 17:35:15 GMT 2025
PRIMARY
MESH
D001554
Created by admin on Mon Mar 31 17:35:15 GMT 2025 , Edited by admin on Mon Mar 31 17:35:15 GMT 2025
PRIMARY
NCI_THESAURUS
C302
Created by admin on Mon Mar 31 17:35:15 GMT 2025 , Edited by admin on Mon Mar 31 17:35:15 GMT 2025
PRIMARY
RS_ITEM_NUM
1601146
Created by admin on Mon Mar 31 17:35:15 GMT 2025 , Edited by admin on Mon Mar 31 17:35:15 GMT 2025
PRIMARY
EVMPD
SUB13010MIG
Created by admin on Mon Mar 31 17:35:15 GMT 2025 , Edited by admin on Mon Mar 31 17:35:15 GMT 2025
PRIMARY
MERCK INDEX
m2338
Created by admin on Mon Mar 31 17:35:15 GMT 2025 , Edited by admin on Mon Mar 31 17:35:15 GMT 2025
PRIMARY Merck Index
NSC
67315
Created by admin on Mon Mar 31 17:35:15 GMT 2025 , Edited by admin on Mon Mar 31 17:35:15 GMT 2025
PRIMARY
EPA CompTox
DTXSID3039242
Created by admin on Mon Mar 31 17:35:15 GMT 2025 , Edited by admin on Mon Mar 31 17:35:15 GMT 2025
PRIMARY
CAS
71-43-2
Created by admin on Mon Mar 31 17:35:15 GMT 2025 , Edited by admin on Mon Mar 31 17:35:15 GMT 2025
PRIMARY
DAILYMED
J64922108F
Created by admin on Mon Mar 31 17:35:15 GMT 2025 , Edited by admin on Mon Mar 31 17:35:15 GMT 2025
PRIMARY
CHEBI
16716
Created by admin on Mon Mar 31 17:35:15 GMT 2025 , Edited by admin on Mon Mar 31 17:35:15 GMT 2025
PRIMARY
RXCUI
1311295
Created by admin on Mon Mar 31 17:35:15 GMT 2025 , Edited by admin on Mon Mar 31 17:35:15 GMT 2025
PRIMARY RxNorm
FDA UNII
J64922108F
Created by admin on Mon Mar 31 17:35:15 GMT 2025 , Edited by admin on Mon Mar 31 17:35:15 GMT 2025
PRIMARY
SMS_ID
100000077173
Created by admin on Mon Mar 31 17:35:15 GMT 2025 , Edited by admin on Mon Mar 31 17:35:15 GMT 2025
PRIMARY
PUBCHEM
241
Created by admin on Mon Mar 31 17:35:15 GMT 2025 , Edited by admin on Mon Mar 31 17:35:15 GMT 2025
PRIMARY
WIKIPEDIA
BENZENE
Created by admin on Mon Mar 31 17:35:15 GMT 2025 , Edited by admin on Mon Mar 31 17:35:15 GMT 2025
PRIMARY
Related Record Type Details
ACTIVE MOIETY